Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2013 by Pedro Bueno, DNA Capital is a prominent global healthcare investment firm headquartered in São Paulo, Brazil, and San Francisco, USA. The firm is dedicated to building leading healthcare companies by partnering with exceptional founders and management teams across various stages of company development. With a strong emphasis on the healthcare sector, DNA Capital has established itself as a key player in the venture capital landscape, focusing on investments that span from early-stage ventures to late-stage private equity. The firm has successfully raised multiple funds and currently manages a portfolio of 24 companies, showcasing its commitment to fostering innovation in healthcare. DNA Capital's reputation is built on its ability to connect, accelerate, and optimize healthcare businesses, making it a sought-after partner for startups looking to make a significant impact in the industry.
DNA Capital exclusively invests in the healthcare sector, targeting a wide range of companies from pre-seed to growth equity stages. The firm is particularly interested in sectors such as biotech, digital health, and other healthcare-related innovations. By providing capital and strategic support, DNA Capital aims to empower companies at all stages of development, ensuring they have the resources needed to thrive in a competitive market. The firm seeks to partner with visionary founders and management teams who are dedicated to transforming healthcare through innovative solutions. With a global investment strategy, DNA Capital focuses on opportunities in Latin America and North America, leveraging its extensive network to connect portfolio companies with valuable resources and expertise. The firm’s investment philosophy emphasizes not only financial backing but also operational support, helping companies navigate the complexities of the healthcare landscape.
DNA Capital boasts a diverse portfolio of 24 companies, highlighting its commitment to investing in innovative healthcare solutions. Notable portfolio companies include DASA, recognized as the fifth largest diagnostics company in the world, and Mafra, a leading provider of integrated healthcare services and products in Latin America. Other significant investments include Alto Pharmacy, Arterys, Beep Saúde, Cambridge Epigenetix, Clover Health, and many more. Each of these companies represents a unique approach to addressing healthcare challenges, from diagnostics and pharmacy services to advanced biotechnology. DNA Capital's strategic investments not only provide financial support but also foster collaboration and innovation within the healthcare ecosystem, positioning its portfolio companies for success in a rapidly evolving industry.
To pitch DNA Capital, founders should email their proposals to contact@dnacapital.com. The firm is open to both warm introductions and cold applications, so ensure your pitch clearly outlines your business model, market potential, and how your company aligns with their healthcare focus.
DNA Capital invests across a wide range of stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, Series D, Series E, and growth equity. This comprehensive approach allows the firm to support companies at various points in their development, from early-stage ventures to more established businesses seeking expansion.
DNA Capital exclusively focuses on the healthcare sector, investing in companies that operate within healthcare, biotech, and digital health. This specialization enables the firm to leverage its expertise and network to drive innovation and growth in these critical areas.
The specific check sizes DNA Capital provides are not detailed in the available information. However, given their investment stages ranging from pre-seed to growth equity, the firm likely tailors its investment amounts to the needs and potential of each portfolio company.
DNA Capital has a global investment focus, with particular emphasis on Latin America and North America. This geographic strategy allows the firm to tap into diverse markets and opportunities within the healthcare sector.
Founders interested in pitching to DNA Capital can reach out via email at contact@dnacapital.com. The firm welcomes inquiries and proposals from startups looking for investment and support in the healthcare sector.
While specific details on portfolio support are not provided, DNA Capital's investment philosophy emphasizes operational support and strategic guidance. The firm aims to empower its portfolio companies by connecting them with valuable resources and expertise within the healthcare ecosystem.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.